These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 33453211)

  • 21. Endogenous opiates and behavior: 2012.
    Bodnar RJ
    Peptides; 2013 Dec; 50():55-95. PubMed ID: 24126281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utility of Nonhuman Primates in Substance Use Disorders Research.
    Banks ML; Czoty PW; Negus SS
    ILAR J; 2017 Dec; 58(2):202-215. PubMed ID: 28531265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antinociceptive, reinforcing, and pruritic effects of the G-protein signalling-biased mu opioid receptor agonist PZM21 in non-human primates.
    Ding H; Kiguchi N; Perrey DA; Nguyen T; Czoty PW; Hsu FC; Zhang Y; Ko MC
    Br J Anaesth; 2020 Oct; 125(4):596-604. PubMed ID: 32819621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of supraspinal Nocistatin on Nociceptin/Orphanin FQ antagonism of selective opioid analgesia.
    Scoto GM; Santangelo N; Parenti C
    Neurosci Lett; 2005 Oct; 387(3):126-9. PubMed ID: 16006036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antinociceptive effects of the ORL1 receptor agonist nociceptin/orphanin FQ in diabetic mice.
    Kamei J; Ohsawa M; Kashiwazaki T; Nagase H
    Eur J Pharmacol; 1999 Apr; 370(2):109-16. PubMed ID: 10323258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomic Tools for the Use of Nonhuman Primates in Translational Research.
    Harding JD
    ILAR J; 2017 Jul; 58(1):59-68. PubMed ID: 28838069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of butorphanol on morphine-induced itch and analgesia in primates.
    Lee H; Naughton NN; Woods JH; Ko MC
    Anesthesiology; 2007 Sep; 107(3):478-85. PubMed ID: 17721251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential barcoding of opioid receptors trafficking.
    Degrandmaison J; Grisé O; Parent JL; Gendron L
    J Neurosci Res; 2022 Jan; 100(1):99-128. PubMed ID: 34559903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of the central opioid system as an antidepressant target in rodent models.
    McHugh KL; Kelly JP
    Prog Brain Res; 2018; 239():49-87. PubMed ID: 30314569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experimental primates and non-human primate (NHP) models of human diseases in China: current status and progress.
    Zhang XL; Pang W; Hu XT; Li JL; Yao YG; Zheng YT
    Dongwuxue Yanjiu; 2014 Nov; 35(6):447-64. PubMed ID: 25465081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-lasting antinociceptive spinal effects in primates of the novel nociceptin/orphanin FQ receptor agonist UFP-112.
    Hu E; Calò G; Guerrini R; Ko MC
    Pain; 2010 Jan; 148(1):107-113. PubMed ID: 19945794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of nociceptin/orphanin FQ and nociceptin opioid peptide receptor in depression and antidepressant effects of nociceptin opioid peptide receptor antagonists.
    Park JY; Chae S; Kim CS; Kim YJ; Yi HJ; Han E; Joo Y; Hong S; Yun JW; Kim H; Shin KH
    Korean J Physiol Pharmacol; 2019 Nov; 23(6):427-448. PubMed ID: 31680765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonhuman primate models in the study of spaceflight stressors: Past contributions and future directions.
    Desai RI; Kangas BD; Limoli CL
    Life Sci Space Res (Amst); 2021 Aug; 30():9-23. PubMed ID: 34281669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Naloxone sensitive orphanin FQ-induced analgesia in mice.
    Rossi GC; Leventhal L; Pasternak GW
    Eur J Pharmacol; 1996 Sep; 311(2-3):R7-8. PubMed ID: 8891615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mu Opioid Receptor Heterodimers Emerge as Novel Therapeutic Targets: Recent Progress and Future Perspective.
    Zhang L; Zhang JT; Hang L; Liu T
    Front Pharmacol; 2020; 11():1078. PubMed ID: 32760281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morphine tolerance and dependence in nociceptin/orphanin FQ transgenic knock-out mice.
    Kest B; Hopkins E; Palmese CA; Chen ZP; Mogil JS; Pintar JE
    Neuroscience; 2001; 104(1):217-22. PubMed ID: 11311544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinct effect of intracerebroventricular and intrathecal injections of nociceptin/orphanin FQ in the rat formalin test.
    Wang JL; Zhu CB; Cao XD; Wu GC
    Regul Pept; 1999 Feb; 79(2-3):159-63. PubMed ID: 10100930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emerging Insights into Mu Opioid Pharmacology.
    Pasternak GW; Childers SR; Pan YX
    Handb Exp Pharmacol; 2020; 258():89-125. PubMed ID: 31598835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bidirectional actions of nociceptin/orphanin FQ on A delta-fibre-evoked responses in rat superficial spinal dorsal horn in vitro.
    Ruscheweyh R; Sandkühler J
    Neuroscience; 2001; 107(2):275-81. PubMed ID: 11731101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of G protein-biased agonists of μ-opioid receptor on addiction-related behaviors.
    Kudla L; Przewlocki R
    Pharmacol Rep; 2021 Aug; 73(4):1033-1051. PubMed ID: 33835467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.